Structure via PubChem · Public domain (PubChem)
tribenoside
Sign in to saveAlso known as GLY401, Tribenosido, Tribenosidum, TBGF
Tribenoside (Glyvenol) is a vasoprotective drug used to treat hemorrhoids. It has mild anti-inflammatory, analgesic, and wound healing properties. Tribenoside stimulates laminin α5 production and laminin-332 deposition to help repair the basement membrane during the wound healing process. It is a mixture of the α- and β-anomers.
Chemical data
- Formula
- C29H34O6
- Molecular weight
- 478.6 g/mol
- IUPAC name
- (3R,4R,5R)-5-[(1R)-1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxyoxolan-3-ol
- SMILES
- CCOC1[C@@H]([C@H]([C@H](O1)[C@@H](COCC2=CC=CC=C2)OCC3=CC=CC=C3)OCC4=CC=CC=C4)O
- InChIKey
- ULLNJSBQMBKOJH-VIVFLBMVSA-N
- XLogP
- 3.9
- Polar surface area
- 66.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- cardiovascular disease, hemorrhoid
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 478.236
Show 5 more facts
- chemical formula
- C₂₉H₃₄O₆
- canonical SMILES
- CCOC1C(C(C(O1)C(COCC2=CC=CC=C2)OCC3=CC=CC=C3)OCC4=CC=CC=C4)O
- isomeric SMILES
- CCOC1[C@@H]([C@H]([C@H](O1)[C@@H](COCC2=CC=CC=C2)OCC3=CC=CC=C3)OCC4=CC=CC=C4)O
- subject has role
- non-steroidal anti-inflammatory drug
- World Health Organisation international non-proprietary name
- tribenoside
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Tribenoside (Glyvenol) is a vasoprotective drug used to treat hemorrhoids. It has mild anti-inflammatory, analgesic, and wound healing properties. Tribenoside stimulates laminin α5 production and laminin-332 deposition to help repair the basement membrane during the wound healing process. It is a mixture of the α- and β-anomers.
Tribenoside has been shown to induce drug hypersensitivity syndrome in association with CMV reactivation.
Excerpted from Wikipedia’s “tribenoside” article, available under the CC BY-SA 4.0 licence.